Hyperparameter Optimizer with Deep Learning-Based Decision-Support Systems for Histopathological Breast Cancer Diagnosis

Histopathological images are commonly used imaging modalities for breast cancer. As manual analysis of histopathological images is difficult, automated tools utilizing artificial intelligence (AI) and deep learning (DL) methods should be modelled. The recent advancements in DL approaches will be hel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2023-01, Vol.15 (3), p.885
Hauptverfasser: Obayya, Marwa, Maashi, Mashael S, Nemri, Nadhem, Mohsen, Heba, Motwakel, Abdelwahed, Osman, Azza Elneil, Alneil, Amani A, Alsaid, Mohamed Ibrahim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Histopathological images are commonly used imaging modalities for breast cancer. As manual analysis of histopathological images is difficult, automated tools utilizing artificial intelligence (AI) and deep learning (DL) methods should be modelled. The recent advancements in DL approaches will be helpful in establishing maximal image classification performance in numerous application zones. This study develops an arithmetic optimization algorithm with deep-learning-based histopathological breast cancer classification (AOADL-HBCC) technique for healthcare decision making. The AOADL-HBCC technique employs noise removal based on median filtering (MF) and a contrast enhancement process. In addition, the presented AOADL-HBCC technique applies an AOA with a SqueezeNet model to derive feature vectors. Finally, a deep belief network (DBN) classifier with an Adamax hyperparameter optimizer is applied for the breast cancer classification process. In order to exhibit the enhanced breast cancer classification results of the AOADL-HBCC methodology, this comparative study states that the AOADL-HBCC technique displays better performance than other recent methodologies, with a maximum accuracy of 96.77%.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers15030885